Insiders · Profile

Dandekar Atul

CSBO at Maze Therapeutics. Filing since 29 Dec 2025. CIK 0002050167

Company

Date

Role

Action

Shares

Amount

Of holding

MAZE Maze Therapeutics, Inc.

29 Sep 2026

CSBO

Sold on a plan

7,500

$202.92K

18.8%

MAZE Maze Therapeutics, Inc.

3 Sep 2026

CSBO

Sold at will

3,243

$84.35K

9.1%

MAZE Maze Therapeutics, Inc.

2 Sep 2026

CSBO

Sold at will

3,191

$84.46K

8.2%

MAZE Maze Therapeutics, Inc.

28 Aug 2026

CSBO

Sold on a plan

7,500

$206.82K

22.2%

MAZE Maze Therapeutics, Inc.

29 Jul 2026

CSBO

Sold on a plan

7,500

$205.03K

22.2%

MAZE Maze Therapeutics, Inc.

29 Jun 2026

CSBO

Sold on a plan

7,500

$210.15K

22.2%

MAZE Maze Therapeutics, Inc.

29 May 2026

CSBO

Sold on a plan

7,500

$197.55K

23.2%

MAZE Maze Therapeutics, Inc.

29 Apr 2026

CSBO

Sold on a plan

7,500

$190.30K

41.7%

MAZE Maze Therapeutics, Inc.

30 Mar 2026

CSBO

Sold on a plan

7,500

$220.02K

41.7%

MAZE Maze Therapeutics, Inc.

27 Feb 2026

CSBO

Sold on a plan

7,500

$340.72K

41.7%

MAZE Maze Therapeutics, Inc.

29 Jan 2026

CSBO

Sold on a plan

7,500

$331.99K

41.7%

MAZE Maze Therapeutics, Inc.

30 Dec 2025

CSBO

Sold on a plan

100

$4.04K

0.9%

MAZE Maze Therapeutics, Inc.

29 Dec 2025

CSBO

Sold on a plan

72,400

$2.94M

87.3%

13 decisions on file.